CTRM (CTRM) Stock Price & Analysis
CTRM (CTRM) rose 0.93% to USD 2.18 as of June 10, 2026 at 01:09 UTC, according to Nexqual real-time market data.
CTRM last closed at USD 2.16; the session ranged USD 2.12–2.19 on volume of 19,867 shares. Market capitalization is $21.06M, with a 52-week range of USD 1.66–2.65 (NCM). Source: Nexqual, June 10, 2026 at 01:09 UTC.
Key Statistics (as of June 10, 2026 at 01:09 UTC)
| Price | USD 2.18 |
|---|---|
| Change | ▲ 0.93% (up) |
| Previous Close | USD 2.16 |
| Open | USD 2.15 |
| Day Range | USD 2.12 – 2.19 |
| 52-Week Range | USD 1.66 – 2.65 |
| Volume | 19,867 shares |
| Market Cap | $21.06M |
| Exchange | NCM |
Technical Analysis (CTRM)
Nexqual's technical model rates CTRM "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 01:09 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 59.31 (neutral) |
| vs SMA50 | Above (USD 1.95) |
| MACD | 0.06 (positive) |
Analyst Ratings (CTRM)
Wall Street analysts rate CTRM "None", per Nexqual as of June 10, 2026 at 01:09 UTC.
| Consensus Rating | None |
|---|
Earnings (CTRM)
| Next Earnings Date | 2026-08-26 |
|---|
Source: Nexqual, June 10, 2026 at 01:09 UTC.
Financials & Fundamentals (CTRM)
| Total Revenue | $82.73M |
|---|---|
| Revenue Growth (YoY) | +4.50% |
| Gross Margin | +48.96% |
| Operating Margin | +10.58% |
| Profit Margin | +103.17% |
| ROE | +16.75% |
| Debt / Equity | 12.87 |
| Current Ratio | 6.88 |
| Total Cash | $211.70M |
| Total Debt | $96.73M |
| Free Cash Flow | $50.24M |
Source: Nexqual, June 10, 2026 at 01:09 UTC.
Financial Health Score (CTRM)
Nexqual rates CTRM's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 01:09 UTC.
| Growth | Mixed — Revenue +4.5% YoY (latest Q), slow |
|---|---|
| Profitability | Strong — Gross margin 49%, operating 11% |
| Balance Sheet | Strong — $212M cash vs $97M debt, net cash position |
| Cash Flow | Strong — FCF $50M, 61% margin |
| Efficiency | Solid — ROE 17%, ROA 0.2% |
Ownership (CTRM)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +3.92% |
| Shares Outstanding | 9.66M |
| Short % of Float | +0.16% |
Source: Nexqual, June 10, 2026 at 01:09 UTC.
Leadership (CTRM)
CTRM is led by Petros Panagiotidis (age 35), Founder, Chairman, CEO, CFO, President & Treasurer, per Nexqual as of June 10, 2026 at 01:09 UTC.
| Founder, Chairman, CEO, CFO, President & Treasurer | Petros Panagiotidis (age 35) |
|---|---|
| Secretary & Independent Non-Executive Director | Dionysios E. Makris (age 44) |
Major Backers & Investors (CTRM)
Notable institutional backers of CTRM include Towerview LLC., Renaissance Technologies, Goldman Sachs, according to Nexqual as of June 10, 2026 at 01:09 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Towerview LLC. | 2.48% |
| Renaissance Technologies | 0.76% |
| Goldman Sachs | 0.22% |
| Apriem Advisors | 0.2% |
| Centiva Capital, LP | 0.11% |
Source: Nexqual, June 10, 2026 at 01:09 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNDL | SNDL Inc. | USD 1.46 | ▲ 2.82% |
| SENS | Senseonics Holdings, Inc. | USD 7.43 | ▲ 11.39% |
| SOS | SOS Limited | USD 0.96 | ▼ 4.95% |
| OCGN | Ocugen, Inc. | USD 1.24 | ▼ 3.13% |
| JAGX | Jaguar Health, Inc. | USD 2.82 | ▲ 0.71% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 01:09 UTC. This page is informational and not investment advice.